Published April 28, 2026 | Version v1
Preprint Open

Ivacaftor-Lumacaftor Combination for CBAVD-Associated CFTR Dysfunction

  • 1. MedicOath

Description

Lumacaftor acts as a CFTR corrector facilitating proper protein folding and trafficking to cell surface, while ivacaftor functions as a potentiator increasing chloride channel gating probability. This dual mechanism addresses both the processing defects and reduced function of mutant CFTR proteins commonly associated with CBAVD, potentially restoring ductal fluid secretion necessary for vas deferens patency.

Notes

IPFS: QmRJXPh6PHA36oE2UwHmwP2TPhhb98rcriU1AkJLfwDg2S. TX: 0x45dd10078474b192b1d35ef7c1af6f68502ada3caead8b075cd7e649e7fff0dd. CC0.

Files

hypothesis.json

Files (403 Bytes)

Name Size Download all
md5:bd260be6dd50040c258b823736fcfa61
403 Bytes Preview Download